Related Experiment Video
Updated: Apr 18, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Halloysite nanotube-based drug delivery system for treating osteosarcoma
Abstract:
Our previous studies have shown that halloysite nanotubes (HNTs) can be doped with a variety of bioactive agents (antibiotics, growth factors, chemotherapeutics) and the agents can be released in a sustained manner. In this study, anti-tumor drugs were loaded into HNTs and tested for their ability to inhibit/kill osteosarcoma cells. Results demonstrate that drugs released from the HNTs can inhibit proliferation or induce apoptosis in the osteosarcoma cells showing the potential application of doped HNTs as an anti-cancer drug delivery system.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drug Delivery Systems: Different Types
Drugs that Stabilize Microtubules

